Home / Biotechnology / Transplant Diagnostics Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2023

Transplant Diagnostics Market Size, Segmentation, Opportunities, Trends, Growth and Industry Forecast To 2023


Organ transplant placement of healthy organ from donor site to replace a damaged or absent organ.Human leukocyte antigens a histocompatibility complex are found on cell surface that regulates adopting of replaced organ. Human leukocyte diagnostic testing (HLA testing/test) is performed foe determination of tissue compatibility between recipient and donor. HLA matching augments graft survival possibility and reduces transplant rejection and failure.

Increasing pool of geriatric population, incidence of chronic diseases leading to organ failure are the major drivers of transplant diagnostics market. However, high costs of transplant procedures and a wide gap in the donor and waiting list, and restrained reimbursement may hold back the growth of this market. Geographically, North America is the largest market for transplant diagnostics followed by Europe. However, trends such as medical tourism, and growing awareness and healthcare expenditure will drive the Asia Pacific and Middle East markets at over than global average growth rate.

The global transplant diagnostics market is segmented on the following bases:

  • Technology
    • Molecular assay
      • PCR based
      • Sequencing based
    • Non-molecular assay
      • Serological
      • MLC
  • Products
    • Equipment and instruments
    • Software
    • Reagents and consumables
  • Application
    • Diagnostics
    • Research
  • End-users
    • Hospitals and transplant centers
    • Third-party testing
    • Research and academia
  • Geography
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • Rest of Europe
    • AsiaPacific
      • Japan
      • China
      • Rest of APA
    • Latin America
    • Middle East and Africa 

Key players identified for transplant diagnostics market include but are not limited to:

Qiagen N.V., Sigma-Aldrich, Olerup Ssp Ab, F. Hoffmann-La Roche, Thermo Fisher Scientific, Inc., Illumina, Inc., Abbott Laboratories, Inc., Immucor Transplant Diagnostics, Inc., Bio-Rad Laboratories, Inc., Omixon Ltd., Luminex Corporation , and severalothers

This report offers:

  • An overview of the global markets fortransplant diagnostics
  • Market trends assessment for the period 2013-2023, with historical information for 2013 &2014, and projections through 2023, with respective CAGRS during 2016-2023
  • Qualitative assessment tools such as market drivers, challenges and future prospects, major commercial events, etc.
  • Market competition scrutiny tools such as market share analysis, attractive investment proposition and others
  • Focus on each level of market segmentation based on product approvals, launch, and current and anticipated market dynamics
  • A general overview of the industry structure
  • Company profiles highlighting key information about the major players operating in the transplant diagnsoticsmarket
Choose License Type
Connect With Us
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients